Search

Specific characteristics of the eggs from nucleus populations of Ancona (AN), Bianca di Saluzzo (BS), Bionda Piemontese (BP), Livorno, Mericanel della Brianza (MB), Mugellese (MU), Siciliana (SI) and Valdarnese (VA) chicken breeds kept in University Research Centres across Italy were evaluated. The physical characteristics considered were whole egg weight and shell, yolk and albumen proportion. The chemical characteristics considered were dry matter (DM), ash and protein content of the yolk and albumen, and the yolk fat. Among the breed groups evaluated in this study, BS and BP produce large eggs that are rich in total crude protein and lipids, with abundant egg whites. MB and MU produce small eggs with a high yolk percentage. AN and SI hens produce medium-small-sized eggs. The heaviest yolks were observed in AN eggs, and the highest shell percentage was found in SI eggs. LB and VA produce medium-large-sized eggs with low yolk lipid content.

In naturally flowing waters, communities are expected to increase their taxonomic and functional diversity as well as increase the complexity of food web architecture along the longitudinal gradient from headwaters to mouth. However, these theories do not necessarily apply to dammed rivers. We analysed fish communities at 12 locations along the 1700 km stretch of the transnational Uruguay River. We determined species richness, beta-diversity and its components (turnover and nestedness), trophic diversity, and isotopic niches at community level, with particular focus on areas upstream and downstream of the four existing dams. We estimated trophic diversity metrics based on diet analysis, and isotopic niche breadth based on Bayesian isotopic niche models. We detected consistent longitudinal changes, supporting predictions from the River Continuum Concept. However, taxonomic richness, trophic diversity, and isotopic niche decreased abruptly immediately downstream of dams, and the component contributing the most to beta diversity was turnover, with the highest values occurring mainly after the cascade of dams in the upper Uruguay River, fitting expectations from the Serial Discontinuity Concept. The dam-free stretches of the Uruguay River allowed the recovery of ecological diversity as fish richness and trophic and isotopic niche increased. The negative impacts of dams should urgently be considered in the Neotropics, where many large dams are projected.

Introduction: The molecular profile of colorectal cancer (CRC) plays a crucial role in understanding patient prognosis and treatment response. Within CRC, a distinct subgroup can be identified by the presence of the BRAF V600E mutation. This specific mutation, classified as Class I of BRAF mutations, is known to be associated with a poor prognosis and resistance to standard therapy. To determine the most effective treatment approach for this specific subgroup of CRC, we conducted a network meta-analysis (NMA) to compare various pharmacological interventions and evaluate their relative effectiveness in BRAF-mutated CRCs. Materials and methods: On July 31, 2023, we conducted a systematic search of PubMed, Cochrane Central Register of Controlled Trials, and Embase. The inclusion criteria were as follows: 1) reporting of outcomes in patients with BRAF-mutated CRC who underwent first-line chemotherapy; 2) reporting of survival information as hazard ratios (HR); and 3) publication in English. The data were combined using HRs for overall and progression-free survival (OS and PFS) using random-effects models. NMA was performed under the Bayesian framework, utilizing the GeMTC package. The relative rankings of the treatments were determined using SUCRA scores. Results: A total of 16 studies were included. When compared to standard chemotherapy (CT) doublets (such as FOLFOX or FOLFIRI), none of the comparison arms demonstrated a gain in OS. CT doublet + bevacizumab did not show significant superiority over either CT doublet alone or 5FU/capecitabine + bevacizumab. FOLFOXIRI and FOLFOXIRI + bevacizumab did not show superiority over any other treatment schedule that was compared. CT doublets + bevacizumab had the highest SUCRA score (0.87), followed by single-agent fluoropyrimidines + bevacizumab (0.61), and FOLFOXIRI (0.56). Regarding PFS, no regimen was found to be superior to the combination of CT doublet plus bevacizumab. However, FOLFOXIRI + bevacizumab + atezolizumab showed a tendency towards better results (HR = 0.26, 95 % CI 0.05–1.1). Conclusions: Our review suggests that a CT doublet with bevacizumab is the most favorable option for OS. However, a reasonable alternative could be a triplet CT without bevacizumab.

Light traps are devices utilized in biomonitoring studies across various aquatic environments. Although light traps are used globally, few studies report their efficacy in capturing fish larvae in the Neotropics. To address this gap, this study aimed to assess the efficacy of light traps in capturing larvae of six fish species commonly found in Neotropical rivers. Additionally, we aimed to evaluate the effect of light color on larval capture. To accomplish this, we selected larvae from six species: Cyprinus carpio, Ctenopharingodon idella, Piaractus mesopotamicus, Pimelodus maculatus, Prochilodus lineatus, and Rhamdia quelen. Each experiment lasted seven days, and six types of traps were tested, including those without light (control) and those with light (green, red, yellow, white, and blue), and installed in triplicate. A total of 18 traps were randomly positioned in earthen ponds containing the six species of interest. Each species was assessed separately in six experiments. Larvae were counted, measured, and identified daily according to their developmental stage. The light traps collected 30,498 larvae, whereas the control traps only collected 39 larvae by the end of the experiment. Larvae from species of the Cypriniformes order were the most captured, while those from the Siluriformes order were least captured. The light traps exhibited selectivity in capturing larvae at different developmental stages, which varied according to species. Traps installed with green lights captured a greater number of larvae and were more efficient at capturing larvae from a wider variety of species. In contrast, traps installed with red light led to the capture of fewer larvae. Therefore, by their ability to attract a greater number of larvae, compared to control, and selectively capture larvae at different developmental stages at variable rates, depending on light source, light traps can be a valuable tool in biomonitoring and managing fish larvae in Neotropical environments.

Abstract Background Pancreatic cancer (PC) first‐line therapy often consists of polychemotherapy regimens, but choosing a second‐line therapy after disease progression, especially following first‐line FOLFIRINOX, remains a clinical challenge. This study presents results from a large, multicenter, retrospective analysis of Italian patients with metastatic PC (mPC) treated with Nab‐paclitaxel/Gemcitabine (AG) as second or later line of treatment. Main objective of the study is to identify prognostic factors that could inform treatment decisions. Methods The study included 160 mPC patients treated with AG in 17 Italian institutions. AG was administered according to labelling dose, until disease progression, unacceptable toxicity or patient refusal. Variations in schedules, dose modifications, supportive measures, and response evaluation were determined by individual clinicians' practice. Results AG was well‐tolerated and exhibited promising clinical activity. The overall response rate (ORR) and the disease control rate (DCR) were 22.5% and 45.6%, respectively. Median progression‐free survival (PFS) and overall survival (OS) were 3.9 and 6.8 months, respectively. Among the patients who received AG as a second‐line therapy (n = 111, 66.9%), median PFS and OS were 4.2 and 7.4 months, respectively. Notably, in the 76 patients (68%) receiving AG after first‐line FOLFIRINOX, an ORR of 19.7% and a DCR of 46.0% were observed, resulting in a median PFS of 3.5 and median OS of 5.7 months. The study identified specific clinical or laboratory parameters (LDH, NLR, fasting serum glucose, liver metastases, ECOG PS, and first‐line PFS) as independent prognostic factors at multivariate level. These factors were used to create a prognostic nomogram that divided patients into three risk classes, helping to predict second‐line OS and PFS. Conclusions This study represents the largest real‐world population of mPC patients treated with AG as a second or later line of therapy. It supports the feasibility of this regimen following first‐line FOLFIRINOX, particularly in patients with specific clinical and laboratory characteristics who derived prolonged benefit from first‐line therapy.

We herein evaluated the hematology and parasitology of Nile tilapia previously raised in an earthen pond and transferred to a recirculating aquaculture system (RAS) to verify any possible influence of RAS on such health parameters. For this, 780 tilapias with an initial average weight and length of 91.05 ± 27.08 g and 17.45 ± 1.91 cm, respectively, were distributed in three tanks (2.0 m3) attached to the RAS, where they remained for 54 d. Throughout the period, water quality parameters remained within the range suitable for the cultivation of the species. Tilapia growth performance was satisfactory in the RAS, reaching a final biomass of close to 300 kg and survival of 98%. Hematological and parasitological analyses at the end of 54 d showed possible stress in RAS, with a significant increase in neutrophils from 12.15 ± 6.66 (earthen pond) to 21.43 ± 11.68% (RAS) and erythrocytes from 1.81 ± 0.24 (earthen pond) to 2.13 ± 0.14 (RAS), and a significant decrease in lymphocytes from 22.4 ± 2.66 (earthen pond) to 13.67 ± 3.38 (RAS). Furthermore, parasitological analysis showed a significant increase in the number of parasitized fish (25% to 63%) and abundance (3.55 ± 6.44 to 9.37 ± 9.99) after 54 d. It was concluded that tilapia cultivation in RAS can cause hematological changes and increase parasitism.

The aim of the present research is to investigate breeders’ management strategies and their effects on reproductive performances in heritage breeds. A total of 468 litters were analysed: Belgian Hare (N = 151), Burgundy Fawn (N = 105), Californian (N = 212). Litter size (born alive), percentage of weaned kits and percentage of selected kits were analysed using a model that included the effects of breed, year of birth, litter’s origin (with three levels: both internal parents = 0, one outside parent = 1 both outside parents = 2) and their interactions (breed*year of birth, breed*litter’s origin, year of birth*litter’s origin, breed*year of birth*litter’s origin). Besides, number of litters per buck and number of litters per doe were analysed using a model with only effect of breed. All these analyses were carried out with SPSS software. No effects of breeds on litter size, percentage of weaned and percentage of selected kits were found. Year of birth presented significant effects on litter size and percentage of weaned kits (p ≤ 0.05). The inclusion of external breeders didn’t significantly influence analysed reproductive data. The number of litters per buck and per doe were not influenced by breed. The frequency of external breeders’ inclusion is breed specific. Data recording is a basic step in phenotypical characterization, our results supply some information about breeders’ management strategies and their effects on some reproductive parameters. Our results show breed specific frequencies of inclusions of external breeders and a positive effect of management procedures (genetic plus environment) on percentage of weaned kits according to the year of birth.HIGHLIGHTS Breeders management and reproductive parameters have been described The most frequent combination is a home bred doe mated to an external male A mean of 2 litters per doe and per buck have calculated in all the breeds The frequency of use of external breeders is breed specific

Abstract This publication is an update of the “Consensus on the therapeutic management of atopic dermatitis - Brazilian Society of Dermatology” published in 2019, considering the novel, targeted-oriented systemic therapies for atopic dermatitis. The initial recommendations of the current consensus for systemic treatment of patients with atopic dermatitis were based on a recent review of scientific published data and a consensus was reached after voting. The Brazilian Society of Dermatology invited 31 experts from all regions of Brazil and 2 international experts on atopic dermatitis who fully contributed to the process. The methods included an e-Delphi study to avoid bias, a literature search and a final consensus meeting. The authors added novel approved drugs in Brazil and the indication for phototherapy and systemic therapy for AD. The therapeutical response to systemic treatment is hereby reported in a suitable form for clinical practice and is also part of this updated manuscript.

Background: Perioperative chemotherapy (CT) is an established therapeutic approach for patients diagnosed with stage IB–III gastric cancer (GC). Objectives: This study aimed to investigate the efficacy of this approach in individuals with GC exhibiting high microsatellite instability (MSI-H). Design: A systematic review was conducted, including studies that provided data on (neo)adjuvant CT outcomes in patients with MSI-H GC. Methods: Systematic searches were conducted in PubMed, Cochrane Central of Controlled Trials, and Embase databases. Data were aggregated using hazard ratios (HRs) to compare overall survival between CT and surgery. Results: Data analysis from 23 studies, including 22,011 patients, revealed that the prevalence of MSI-H is 9.8%. Administration of adjuvant or perioperative CT did not significantly reduce the risk of death or relapse in patients with MSI-H GC (HR = 0.8, 95% CI 0.54–1.16; p = 0.24 and HR = 0.84, 95% CI 0.59–1.18; p = 0.31, respectively). Conclusion: Chemotherapy did not benefit patients diagnosed with MSI-H nonmetastatic GC but rather will be integrated with immune checkpoint inhibitors in the near future.

Abstract In this study, we analyzed the altitudinal distribution and body condition of the juvenile migratory fish Megaleporinus obtusidens and Salminus brasiliensis in the Uruguay River, a South American subtropical river. We used the presence/absence data and condition factor (K) of juveniles as indicators to try to characterize some recruitment patterns of migratory fish in the main channel of the Uruguay River. Gillnet sampling was conducted during two reproductive years, 2015-2016 and 2016-2017 (November and March of each reproductive year), in three Uruguay River stretches at different levels of altitude. The nets remained in the water for 10-12 hours per night or day for 10 days during each field trip (NOV-15, MAR-16, NOV-16, and MAR-17). The abundance of M. obtusidens juveniles were similar between the two reproductive years, whereas S. brasiliensis capture was higher during the 2015-2016 reproductive year. The probability of finding M. obtusidens juveniles in the Uruguay River was negatively correlated (p < 0.05) with the altitudinal gradient of the sampling points, as shown by the GLM model. For S. brasiliensis, the logit model indicated a non-significant probabilistic relationship (p > 0.05) between the presence of juveniles of this fish species and the altitude gradient. Regarding the body condition of juveniles, the water quality of the sampling points did not affect the juvenile condition factor for either species; however, a positive relationship (p < 0.05) was found with the water level for both species, even with an adjusted R2 of 0.13 for M. obtusidens and 0.48 to S. brasiliensis. Altitude gradient and water level were factors that may affect the juvenile distribution and body condition of these species, respectively, in the Uruguay River. Therefore, this information can be used in hydropower generation policies to conserve migratory fish populations in the Uruguay River Basin.

Abstract Background The NAPOLI‐I trial showed better outcome of nanoliposomal irinotecan (nal‐IRI) plus 5‐fluorouracil/leucovorin (5‐FU/LV) compared to 5‐FU/LV in patients with advanced pancreatic ductal adenocarcinoma cancer (advPDAC) progressed to gemcitabine‐based therapy. This study aims to explore the real‐world efficacy and safety of 5‐FU/LV‐nal‐IRI. Methods This is a retrospective multicenter analysis including advPDAC patients receiving 5‐FU/LV‐nal‐IRI after failure of gemcitabine‐based therapy. Survival analyses were performed using Kaplan–Meier method, univariate and multivariate analyses by Cox regression. Results A total of 296 patients (median age 64.4 years, ECOG PS ≥1 in 56% of cases) were treated at 11 Italian institutions between 2016 and 2018. 34% of them underwent primary tumor resection, and 79% received gemcitabine‐nabpaclitaxel as first line. 5‐FU/LV‐nal‐IRI was administered as second‐line in 73% of cases. Objective response and disease control rate were 12% and 41%, respectively. Treatment was well tolerated with dose reductions in 50% of patients but no one permanent discontinuation; the commonest grade ≥3 toxicities were neutropenia (14%) and diarrhea (12%). Median PFS and OS from 5‐FU/LV‐nal‐IRI initiation was 3.2 and 7.1 months, respectively. Conclusions These real‐world data confirm the 5‐FU/LV‐nal‐IRI efficacy and safety in advPDAC patients progressed to gemcitabine‐based therapy, with outcomes comparable to NAPOLI‐1, even in a less‐selected population and with more modern therapeutic algorithm.

Colorectal cancer represents an important oncological challenge both for its incidence, which makes it an important health problem, and for its biological complexity, which has made clinical results very difficult in terms of outcome for this category of patients. To date these diseases should not be treated as a single entity but it is necessary to distinguish colorectal cancers based on characteristics that nowadays are essential to have greater therapeutic benefits. These include the sideness of the disease, the state of microsatellites, the presence of prognostic and predictive mutations of response to treatments currently available in clinical practice, which are associated with new therapeutic targets. The greatest challenge in the future will be to circumvent the resistance mechanisms that make this disease very difficult to treat with good long-term results by studying effective combination treatments with a good toxicity profile. Once such combinations or targeted treatments are consolidated, it will be desirable to shift the best therapies to the first line treatment to make them immediately accessible to the patient. It will also be essential to refine the selection of patients who can benefit from these treatments.